Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities (Q34980032)

5 August 2017

1 reference

title

Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities (English)

1 reference

5 August 2017

1 reference

acute myeloid leukemia

1 reference

Pedersen-Bjergaard J

1

1 reference

5 August 2017

Christiansen DH

series ordinal

2

1 reference

5 August 2017

Andersen MK

series ordinal

3

1 reference

5 August 2017

Skovby F

series ordinal

4

1 reference

5 August 2017

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

11

1 reference

5 August 2017

2177-2184

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402764

5 August 2017

0 references

cites work

Multiple myeloma and acute myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Hematologic neoplasia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

DNA damage and mutagenesis induced by nitrogen mustards

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Delineation of multiple deleted regions in 7q in myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and/or 7 and its possible relationship to replication error phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Distinct haematological disorder with deletion of long arm of no. 5 chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Leukemia following chemotherapy for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Increase therapy-related leukemia secondary to breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Oncogenic transcription factors in the human acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Developments in cytogenetics and oncogenes in acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Topoisomerase II is a structural component of mitotic chromosome scaffolds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Frequent chromosomal translocations induced by DNA double-strand breaks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Relationship of leukemia risk to radiation dose following cancer of the uterine corpus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

BENZENE AND LEUKEMIA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Leukaemia in benzene workers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Benzene and leukemia. An epidemiologic risk assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Leukaemia and smoking habits among United States veterans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Cigarette smoking and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Association between smoking and leukemia in two American Cancer Society prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402764

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402764

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference